Hanmi Pharm. Co., Ltd. (128940.KS)
- Previous Close
310,000.00 - Open
311,000.00 - Bid --
- Ask --
- Day's Range
308,500.00 - 314,500.00 - 52 Week Range
256,372.55 - 377,000.00 - Volume
21,794 - Avg. Volume
42,388 - Market Cap (intraday)
3.94T - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 30, 2024
- Forward Dividend & Yield 500.00 (0.16%)
- Ex-Dividend Date Dec 27, 2023
- 1y Target Est
414,739.00
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company was founded in 1973 and is based in Hwaseong-si, South Korea.
www.hanmipharm.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 128940.KS
Performance Overview: 128940.KS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 128940.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 128940.KS
Valuation Measures
Market Cap
3.94T
Enterprise Value
4.26T
Trailing P/E
26.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.64
Price/Book (mrq)
4.12
Enterprise Value/Revenue
2.86
Enterprise Value/EBITDA
13.27
Financial Highlights
Profitability and Income Statement
Profit Margin
9.81%
Return on Assets (ttm)
7.35%
Return on Equity (ttm)
15.68%
Revenue (ttm)
1.49T
Net Income Avi to Common (ttm)
146.23B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
255.18B
Total Debt/Equity (mrq)
52.07%
Levered Free Cash Flow (ttm)
156.41B
Research Analysis: 128940.KS
Company Insights: 128940.KS
128940.KS does not have Company Insights